SeaStar Medical Holding Corp
ICUCW0.038USD
+0.006+18.46%
Close 04/23, 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of SeaStar Medical Holding Corp Company
SeaStar Medical Holding Corporation is a commercial-stage medical technology company, which is focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. It has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).
Company Info
Company codeICUCW
Company nameSeaStar Medical Holding Corp
IPO dateJan 26, 2021
Founded at2020
CEOMr. Eric Schlorff
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address3513 Brighton Blvd
CityDENVER
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code80216
Phone18444278100
Websitehttps://seastarmedical.com
Company codeICUCW
IPO dateJan 26, 2021
Founded at2020
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Schlorff
Mr. Eric Schlorff
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. David A. Green, CPA
Mr. David A. Green, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. John Neuman
Mr. John Neuman
Director
Director
--
--
Dr. Kevin Chung, M.D.
Dr. Kevin Chung, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Richard (Rick) Barnett
Mr. Richard (Rick) Barnett
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kenneth (Ken) Van Heel
Mr. Kenneth (Ken) Van Heel
Independent Director
Independent Director
--
--
Ms. Jody Cain
Ms. Jody Cain
LHA Investor Relations
LHA Investor Relations
--
--
Mr. Allan Collins, M.D.
Mr. Allan Collins, M.D.
Independent Director
Independent Director
--
--
Ms. Bernadette N Vincent
Ms. Bernadette N Vincent
Independent Director
Independent Director
--
--
Ms. Jennifer A (Jen) Baird
Ms. Jennifer A (Jen) Baird
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Schlorff
Mr. Eric Schlorff
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. David A. Green, CPA
Mr. David A. Green, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. John Neuman
Mr. John Neuman
Director
Director
--
--
Dr. Kevin Chung, M.D.
Dr. Kevin Chung, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Richard (Rick) Barnett
Mr. Richard (Rick) Barnett
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kenneth (Ken) Van Heel
Mr. Kenneth (Ken) Van Heel
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholder
Update time: Sun, Feb 23
Update time: Sun, Feb 23
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Other
100.00%
Shareholder Statistics
Shareholder
Proportion
Other
100.00%
Type
Shareholder
Proportion
Other
100.00%
Institutional Shareholding
Update time: Mon, Mar 3
Update time: Mon, Mar 3
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
36
1.61M
0.00%
-1.87M
2024Q4
40
1.61M
0.00%
-1.96M
2024Q3
48
1.73M
0.00%
-2.82M
2024Q2
49
1.82M
0.00%
-2.85M
2024Q1
48
1.89M
0.00%
-3.04M
2023Q4
48
2.81M
0.00%
-2.65M
2023Q3
47
3.81M
0.00%
-1.48M
2023Q2
47
4.11M
0.00%
-1.50M
2023Q1
47
4.34M
0.00%
-1.40M
2022Q4
45
4.49M
0.00%
-413.24K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Ayrton Capital LLC
250.00K
0%
--
--
Sep 30, 2023
Boothbay Fund Management, LLC
245.20K
0%
--
--
Dec 31, 2024
ATW Spac Management LLC
245.20K
0%
--
--
Dec 31, 2024
Linden Advisors L.P.
218.07K
0%
--
--
Dec 31, 2024
Goldman Sachs & Company, Inc.
211.38K
0%
--
--
Dec 31, 2024
LMR Partners LLP
125.00K
0%
+125.00K
--
Dec 31, 2024
Equitec Proprietary Markets, LLC
80.40K
0%
--
--
Dec 31, 2024
Walleye Trading, LLC
57.68K
0%
-39.13K
-40.42%
Dec 31, 2024
Clear Street LLC
47.29K
0%
-300.00
-0.63%
Dec 31, 2024
Tenor Capital Management Co., L.P.
40.00K
0%
--
--
Dec 31, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data